Is Triphala (Terminalia chebula, T. bellerica, Emblica officinalis) Safe with Triphala?
Free · No account · based on published sources including NIH ODS, FDA drug labels, and peer-reviewed literature
Discontinue Triphala at least 2 weeks before any surgical procedure.
Why this interaction occurs
Triphala contains high levels of tannins and gallic acid with documented in vitro and limited in vivo antiplatelet activity. Terminalia chebula has demonstrated inhibition of platelet aggregation and potentiation of anticoagulant effects in animal models. Case reports and pharmacovigilance data suggest increased bleeding risk when combined with anticoagulants.
Evidence
Evidence level: moderate.
Reported safety data
The FDA’s adverse event reporting system (FAERS) has received 48 reports mentioning Triphala. This reflects reported cases involving the medication in general — not confirmed causation, and not specific to the Triphala + supplement combination on this page.
FAERS reports are voluntary and cannot prove that a drug caused an event. Do not use report counts to assess the safety of this specific drug-supplement pair.
Frequently asked questions
All Triphala (Terminalia chebula, T. bellerica, Emblica officinalis) interactions → · All Triphala interactions →
Already checked this one — check your whole list
Educational only — not medical advice.
Always confirm with your doctor or pharmacist.